BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33693987)

  • 21. Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes.
    Potter KJ; Boudreau V; Bonhoure A; Tremblay F; Lavoie A; Carricart M; Senior PA; Rabasa-Lhoret R
    J Cyst Fibros; 2023 Jan; 22(1):50-58. PubMed ID: 36028423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
    Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.
    Mannik LA; Chang KA; Annoh PQK; Sykes J; Gilmour J; Robert R; Stephenson AL
    J Cyst Fibros; 2018 Jul; 17(4):536-541. PubMed ID: 29680365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
    Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
    Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.
    Piona C; Volpi S; Zusi C; Mozzillo E; Tosco A; Franzese A; Raia V; Boselli ML; Trombetta M; Cipolli M; Bonadonna RC; Maffeis C
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1793-e1802. PubMed ID: 33331877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
    Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
    Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
    J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
    Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.
    Colomba J; Boudreau V; Lehoux-Dubois C; Desjardins K; Coriati A; Tremblay F; Rabasa-Lhoret R
    J Cyst Fibros; 2019 Jul; 18(4):551-556. PubMed ID: 30711385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index.
    Tommerdahl KL; Brinton JT; Vigers T; Cree-Green M; Zeitler PS; Nadeau KJ; Chan CL
    J Cyst Fibros; 2021 Mar; 20(2):339-345. PubMed ID: 32928701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.